with 77% receiving upfront surgery and 85% achieving complete macroscopic resection, we suspect the 28-day mortality would far exceed 1.8%.
Whilst it is claimed there is no difference in stage between the two centres, a Chi squared test on the presented data shows a highly significant difference with centre A having more stage 3A and 4 disease than centre B. This would be expected in a centre such as centre A with a more aggressive surgical approach.
Most significantly, however, concerns lie with the choice of statistical tests used to describe the overall survival from these two centres, and we would be grateful if the authors could provide the median (rather than the mean) survival figures for the total cohort and surgical cohort for the two centres. The mean is not the standard descriptive statistic for data that are not normally distributed (such as survival), as it is prone to be significantly affected by outliers (i.e. long-term survivors) and indeed is not the test used by the authors in previous publications. Additionally, a Kaplan-Meier graph of the individual centres is not available, again making it difficult to see where the median survival may lie.
Finally, could the authors please explain why, according to Table 1 , only nine patients received palliative treatment and yet the Kaplan-Meier curve presented in Fig. 2a clearly demonstrates more than nine events occurring.
